BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28273905)

  • 1. NKG2D modulates aggravation of liver inflammation by activating NK cells in HBV infection.
    Wang Y; Wang W; Shen C; Wang Y; Jiao M; Yu W; Yin H; Shang X; Liang Q; Zhao C
    Sci Rep; 2017 Mar; 7(1):88. PubMed ID: 28273905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
    Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Killer p46 Controls Hepatitis B Virus Replication and Modulates Liver Inflammation.
    Li W; Jiang Y; Wang X; Jin J; Qi Y; Chi X; Zhang H; Feng X; Niu J
    PLoS One; 2015; 10(8):e0135874. PubMed ID: 26291078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV infection.
    Tang L; Li Q; Chen L; Li X; Gu S; He W; Pan Q; Wang L; Sun J; Yi X; Li Y
    J Med Virol; 2023 Oct; 95(10):e29142. PubMed ID: 37815034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural Killer Group 2A Expressed on Both Peripheral CD3
    Yi RT; Niu YH; Liu HL; Zhang TY; Yang YC; Zhang Y; Yin DL; Chen TY; Zhao YR
    J Interferon Cytokine Res; 2016 Dec; 36(12):689-697. PubMed ID: 27828717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
    Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
    PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased peripheral natural killer cells activity in the immune activated stage of chronic hepatitis B.
    Li Y; Wang JJ; Gao S; Liu Q; Bai J; Zhao XQ; Hao YH; Ding HH; Zhu F; Yang DL; Zhao XP
    PLoS One; 2014; 9(2):e86927. PubMed ID: 24520324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
    Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
    PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
    Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
    Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated natural killer cells accelerate liver damage in patients with chronic hepatitis B virus infection.
    Zheng Q; Zhu YY; Chen J; Ye YB; Li JY; Liu YR; Hu ML; Zheng YC; Jiang JJ
    Clin Exp Immunol; 2015 Jun; 180(3):499-508. PubMed ID: 25639451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT1 is associated with NK cell dysfunction by downregulating NKG2D transcription in chronic HBV-infected patients.
    Huang X; Mo Q; Fu T; Liu Y; Diao B
    Immunobiology; 2022 Nov; 227(6):152272. PubMed ID: 36122437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar frequencies, phenotype and activation status of intrahepatic NK cells in chronic HBV patients after long-term treatment with tenofovir disoproxil fumarate (TDF).
    Tjwa ET; Zoutendijk R; van Oord GW; Boeijen LL; Reijnders JG; van Campenhout MJ; de Knegt RJ; Janssen HL; Woltman AM; Boonstra A
    Antiviral Res; 2016 Aug; 132():70-5. PubMed ID: 27237584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
    Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
    J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8
    Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
    Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
    Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
    Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.
    Hodge G; Barnawi J; Jurisevic C; Moffat D; Holmes M; Reynolds PN; Jersmann H; Hodge S
    Clin Exp Immunol; 2014 Oct; 178(1):79-85. PubMed ID: 24894428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response pattern varies with the natural history of chronic hepatitis B.
    Wang WT; Zhao XQ; Li GP; Chen YZ; Wang L; Han MF; Li WN; Chen T; Chen G; Xu D; Ning Q; Zhao XP
    World J Gastroenterol; 2019 Apr; 25(16):1950-1963. PubMed ID: 31086463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation.
    Kupke P; Brucker J; Wettengel JM; Protzer U; Wenzel JJ; Schlitt HJ; Geissler EK; Werner JM
    Viruses; 2024 May; 16(5):. PubMed ID: 38793623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower NKG2D expression in hepatic natural killer cells predicts poorer prognosis for chronic hepatitis B patients with cirrhosis.
    Ma Y; Ping D; Huang K; Tao Y; Peng Y; Sun X; Liu C
    Hum Immunol; 2024 May; 85(3):110775. PubMed ID: 38493049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.